Dr. Tingley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Parnassus Ave Ste 300
San Francisco, CA 94143Phone+1 415-353-2873Fax+1 415-353-2528
Education & Training
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 2000 - 2014
Publications & Presentations
PubMed
- Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers...Amos Baruch, Sofia Mosesova, John D. Davis, Nageshwar Budha, Alexandr Vilimovskij
The American Journal of Cardiology. 2018-02-12 - 15 citationsA phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin...Amos Baruch, Diana Luca, Robert Kahn, Kyra J. Cowan, Maya Leabman
Clinical Cardiology. 2017-07-01 - 43 citationsEffects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coron...Amos Baruch, Sofia Mosesova, John D. Davis, Nageshwar Budha, Alexandr Vilimovskij
The American Journal of Cardiology. 2017-05-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: